Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0DX4J
|
|||
Former ID |
DCL001073
|
|||
Drug Name |
P1446A-05
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
Company |
Nicholas Piramal
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H19ClF3NO5
|
|||
Canonical SMILES |
CN1CCC(C1CO)C2=C(C=C(C3=C2OC(=CC3=O)C4=C(C=C(C=C4)C(F)(F)F)Cl)O)O
|
|||
InChI |
1S/C22H19ClF3NO5/c1-27-5-4-12(14(27)9-28)19-15(29)7-16(30)20-17(31)8-18(32-21(19)20)11-3-2-10(6-13(11)23)22(24,25)26/h2-3,6-8,12,14,28-30H,4-5,9H2,1H3/t12-,14+/m1/s1
|
|||
InChIKey |
MRPGRAKIAJJGMM-OCCSQVGLSA-N
|
|||
CAS Number |
CAS 1000023-04-0
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Liposarcoma: molecular genetics and therapeutics. Sarcoma. 2011;2011:483154. | |||
REF 2 | Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov. 2009 Jul;8(7):547-66. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.